Literature DB >> 20483508

[Acetazolamide in high altitude trips].

Francisco Javier García Nicolás.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20483508      PMCID： PMC7025043          DOI： 10.1016/j.aprim.2010.02.003

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  6 in total

Review 1.  Illnesses at high altitude.

Authors:  Robert B Schoene
Journal:  Chest       Date:  2008-08       Impact factor: 9.410

2.  Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial.

Authors:  Peter Hillenbrand; Anil K Pahari; Yuen Soon; Deepak Subedi; Rajan Bajracharya; Puncho Gurung; Barun K Lal; Ramesh Marahatta; Santosh Pradhan; Dilip Rai; Shailendra Sharma
Journal:  Wilderness Environ Med       Date:  2006       Impact factor: 1.518

Review 3.  Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review.

Authors:  L Dumont; C Mardirosoff; M R Tramèr
Journal:  BMJ       Date:  2000-07-29

4.  Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).

Authors:  Jeffrey H Gertsch; Buddha Basnyat; E William Johnson; Janet Onopa; Peter S Holck
Journal:  BMJ       Date:  2004-03-11

5.  Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange.

Authors:  C K Grissom; R C Roach; F H Sarnquist; P H Hackett
Journal:  Ann Intern Med       Date:  1992-03-15       Impact factor: 25.391

6.  Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.

Authors:  Martha C Tissot van Patot; Guy Leadbetter; Linda E Keyes; Kirsten M Maakestad; Sheryl Olson; Peter H Hackett
Journal:  High Alt Med Biol       Date:  2008       Impact factor: 1.981
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.